Oracle, Moderna, Goldman Sachs Option Activity Surges on Friday

Notable Friday option activity was seen in Oracle Corp (ORCL), Moderna Inc (MRNA), and Goldman Sachs Group Inc (GS). ORCL saw 904,524 contracts traded, representing 90.5 million underlying shares. MRNA saw 242,485 contracts traded, representing 24.2 million underlying shares. GS saw 20,565 contracts traded, representing 2.1 million underlying shares.

Notable Friday option activity was observed in Oracle Corp (ORCL), Moderna Inc (MRNA), and Goldman Sachs Group Inc (GS). ORCL saw 904,524 contracts traded, representing 90.5 million underlying shares. MRNA saw 242,485 contracts traded, representing 24.2 million underlying shares. GS saw 20,565 contracts traded, representing 2.1 million underlying shares.

Oracle Corp reported a significant increase in option activity, with 904,524 contracts traded, indicating substantial interest from investors. This activity was driven by the company's robust financial performance, as highlighted in its Form 10-Q report for the third quarter. Total revenues increased by 12%, with cloud and software revenues contributing to 86% of the total revenue growth ORACLE CORP SEC 10-Q Report^[1].

Moderna Inc experienced a notable drop in its stock price following a report that Trump administration health officials plan to link Covid vaccines to the deaths of 25 children. The report came as Health and Human Services Secretary Robert F. Kennedy Jr. moves to change vaccine policy in the U.S. Pfizer, Moderna shares fall on report that Trump officials will link child deaths to Covid shots^[2]. Despite the report, Moderna maintains that the safety of its vaccine is rigorously monitored by the company, the FDA, and regulators in more than 90 countries Pfizer, Moderna shares fall on report that Trump officials will link child deaths to Covid shots^[2].

Goldman Sachs Group Inc saw 20,565 contracts traded, representing 2.1 million underlying shares. The company reported a quarterly EPS of $10.91, exceeding analyst estimates, and experienced a 14.5% increase in revenue year-over-year. Institutional investors and hedge funds own 71.21% of the company's stock 6,516 Shares in The Goldman Sachs Group, Inc. $GS Bought by Ransom Advisory Ltd^[3].

The increased option activity in these companies reflects investor interest in their respective financial performances and strategic developments. Investors should closely monitor these companies' future earnings and market developments to make informed investment decisions.